New Agents and New Applications of Targeted Therapy For Hormone Receptor Positive Breast Cancer
Alberto Montero, MD, MBA, CPHQ
Multiple Myeloma: Triplet? Quadruplet? What is The Best Frontline Therapy and Next Line after First Relapse?
Sagar Lonial, MD, FACP
Novel Advances in Radiation Oncology Beyond SRS and Proton Therapy: What Is Next?
Puneeth Iyengar, MD, PhD
Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy
Christian Rolfo, MD, PhD, MBA, Dr.h.c.
Are The New Changes in Congress an Answer for Inequity in Terms of Access to Molecular Testing and New Cancer Agents?
Kashyap Patel, MD, ABOIM
Cost of Medications: How to Make Them Affordable—Are We on the Right Direction?
Dina Dumercy McHenry, PharmD, MBA, BCOP, CSSGB
